GlucoTrack Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for GlucoTrack, Inc. (GCTK) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-22.60-7.10-4.44-4.07-2.70
Depreciation & Amortization0.040.010.020.040.05
Stock Based Compensation0.170.340.440.220.19
Change in Working Capital0.070.190.18-0.05-1.03
Change in Accounts Receivable0.000.000.000.070.01
Change in Inventory0.000.000.000.29-0.09
Change in Accounts Payable0.260.170.07-0.26-0.71
Change in Other Working Capital9.030.020.060.04-0.25
Other Operating Activities9.030.000.060.04-0.01
Net Cash from Operating Activities-12.49-6.56-3.73-3.77-3.50
Investing Activities
Capital Expenditures-0.100.000.000.00-0.05
Net Cash from Investing Activities-0.100.000.000.00-0.05
Financing Activities
Debt Repayment4.380.000.000.000.00
Common Stock Issued9.288.730.000.0012.25
Other Financing Activities0.090.000.000.000.76
Net Cash from Financing Activities13.748.730.000.0013.01
Summary
Effect of Forex Changes on Cash-0.020.00-0.050.000.00
Net Change in Cash1.152.17-3.73-3.779.41
Cash at Beginning of Period4.502.336.119.890.00
Cash at End of Period5.634.502.336.110.00
Free Cash Flow-12.59-6.56-3.73-3.77-3.55